These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 30080294)
21. Silybin and its congeners: from traditional medicine to molecular effects. Křen V; Valentová K Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639 [TBL] [Abstract][Full Text] [Related]
22. The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence. Marmouzi I; Bouyahya A; Ezzat SM; El Jemli M; Kharbach M J Ethnopharmacol; 2021 Jan; 265():113303. PubMed ID: 32877720 [TBL] [Abstract][Full Text] [Related]
23. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Pradhan SC; Girish C Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517 [TBL] [Abstract][Full Text] [Related]
24. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom. Poppe L; Petersen M Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292 [TBL] [Abstract][Full Text] [Related]
25. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study. Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761 [TBL] [Abstract][Full Text] [Related]
26. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Fenclova M; Novakova A; Viktorova J; Jonatova P; Dzuman Z; Ruml T; Kren V; Hajslova J; Vitek L; Stranska-Zachariasova M Sci Rep; 2019 Jul; 9(1):11118. PubMed ID: 31366891 [TBL] [Abstract][Full Text] [Related]
27. Flavonolignans from Aspergillus iizukae, a fungal endophyte of milk thistle (Silybum marianum). El-Elimat T; Raja HA; Graf TN; Faeth SH; Cech NB; Oberlies NH J Nat Prod; 2014 Feb; 77(2):193-9. PubMed ID: 24456525 [TBL] [Abstract][Full Text] [Related]
28. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567 [TBL] [Abstract][Full Text] [Related]
30. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838 [TBL] [Abstract][Full Text] [Related]
31. A New Class of Synthetic Flavonolignan-Like Dimers: Still Few Molecules, but with Attractive Properties. Romanucci V; Di Fabio G; Zarrelli A Molecules; 2018 Dec; 24(1):. PubMed ID: 30597952 [TBL] [Abstract][Full Text] [Related]
32. Protective Effect of Silybum marianum and Silibinin on Endothelial Cells Submitted to High Glucose Concentration. Palomino OM; Gouveia NM; Ramos S; Martín MA; Goya L Planta Med; 2017 Jan; 83(1-02):97-103. PubMed ID: 27525510 [No Abstract] [Full Text] [Related]
33. Accumulation of silymarin in milk thistle seeds under drought stress. Keshavarz Afshar R; Chaichi MR; Ansari Jovini M; Jahanzad E; Hashemi M Planta; 2015 Sep; 242(3):539-43. PubMed ID: 25708739 [TBL] [Abstract][Full Text] [Related]
35. [Flavonolignans - compounds not only for liver treatment]. Bijak M Pol Merkur Lekarski; 2017 Jan; 42(247):34-37. PubMed ID: 28134230 [TBL] [Abstract][Full Text] [Related]
36. Milk thistle (Silybum marianum) for the therapy of liver disease. Flora K; Hahn M; Rosen H; Benner K Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229 [TBL] [Abstract][Full Text] [Related]
37. The silymarin composition… and why does it matter??? Chambers CS; Holečková V; Petrásková L; Biedermann D; Valentová K; Buchta M; Křen V Food Res Int; 2017 Oct; 100(Pt 3):339-353. PubMed ID: 28964357 [TBL] [Abstract][Full Text] [Related]
38. Metabolism, Transport and Drug-Drug Interactions of Silymarin. Xie Y; Zhang D; Zhang J; Yuan J Molecules; 2019 Oct; 24(20):. PubMed ID: 31615114 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic, hepatoprotective and antioxidant activities of Ahmed HS; Mohamed WR; Moawad AS; Owis AI; Ahmed RR; AbouZid SF Nat Prod Res; 2020 Dec; 34(24):3540-3544. PubMed ID: 30856005 [TBL] [Abstract][Full Text] [Related]